Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.
Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.
复制标题
DOI:
10.1021/acs.bioconjchem.5b00516
复制
发表时间:
2016-02-17
影响因子:
4.7
通讯作者:
Morse DL
中科院分区:
文献类型:
--
作者:
Cohen AS;Patek R;Enkemann SA;Johnson JO;Chen T;Toloza E;Vagner J;Morse DL
In the United States, lung cancer is the leading cause of cancer deaths and ranks second in the number of new cases annually among all types of cancers. Better methods or tools for diagnosing and treating this disease are needed to improve patient outcomes. The delta opioid receptor (δOR) is reported to be overexpressed in lung cancers and not expressed in normal lung. Thus, we decided to develop a lung cancer-specific imaging agent targeting this receptor. We have previously developed a δOR–targeted fluorescent imaging agent based on a synthetic peptide antagonist (Dmt-Tic) conjugated to a Cy5 fluorescent dye. In this work, we describe the synthesis of Dmt-Tic conjugated to a longer wavelength near-infrared fluorescent (NIRF) dye, Li-cor IR800CW. Binding affinity of Dmt-Tic-IR800 for the δOR was studied using lanthanide time-resolved fluorescence (LTRF) competitive binding assays in cells engineered to overexpress the δOR. In addition, we identified lung cancer cell lines with high- and low-endogenous expression of the δOR. We confirmed protein expression in these cell lines using confocal fluorescence microscopy imaging and used this technique to estimate the cell-surface receptor number in the endogenously expressing lung cancer cell lines. The selectivity of Dmt-Tic-IR800 for imaging of the δOR in vivo was shown using both engineered cell lines and endogenously expressing lung cancer cells in subcutaneous xenograft models in mice. In conclusion, the δOR–specific fluorescent probe developed in this study displays excellent potential for imaging of lung cancer.
登录
查看更多内容
影响因子:
16.6
作者:
Asanuma D;Sakabe M;Kamiya M;Yamamoto K;Hiratake J;Ogawa M;Kosaka N;Choyke PL;Nagano T;Kobayashi H;Urano Y
通讯作者:
Urano Y
影响因子:
3.1
作者:
Keereweer, Stijn;Kerrebijn, Jeroen D. F.;van Driel, Pieter B. A. A.;Xie, Bangwen;Kaijzel, Eric L.;Snoeks, Thomas J. A.;Que, Ivo;Hutteman, Merlijn;van der Vorst, Joost R.;Mieog, J. Sven D.;Vahrmeijer, Alexander L.;van de Velde, Cornelis J. H.;de Jong, Robert J. Baatenburg;Lowik, Clemens W. G. M.
通讯作者:
Lowik, Clemens W. G. M.
影响因子:
3.1
作者:
Collier, TL;Schiller, PW;Waterhouse, RN
通讯作者:
Waterhouse, RN
影响因子:
7.3
作者:
Amanda Shanks Huynh;Chung, Woo Jin;Vagner, Josef
通讯作者:
Vagner, Josef
影响因子:
2.8
作者:
Black, Kvar C.;Kirkpatrick, Nathaniel D.;Romanowski, Marek
通讯作者:
Romanowski, Marek